Nuclear Medicine and Biology:
Official Journal of the SRS
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.
Feb 2018 Issue (Vol. 57) Table of Contents
Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors
Martin Prause, Sabrina Niedermoser, Carmen Wängler, Clemens Decristoforo, Uwe Seibold, Stephanie Riester, Takahiro Taguchi, Ralf Schirrmacher, Gert Fricker, Björn Wängler
Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates
Vladimir Stepanov, Akihiro Takano, Ryuji Nakao, Nahid Amini, Shotaro Miura, Tomoaki Hasui, Haruhide Kimura, Takahiko Taniguchi, Christer Halldin
Alkaline degradation of lyophilized DMSA prior to labeling with 99mTc: Identification and development of the degradation pathway by HPLC and MS
Erika V. Almeida, Samuel L. De Brito
Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers
Lukas Nics, Britta Steiner, Eva-Maria Klebermass, Cecile Philippe, Markus Mitterhauser, Marcus Hacker, Wolfgang Wadsak
Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting
Georgios Paparidis, Melpomeni Akrivou, Vicky Tsachouridou, Antonio Shegani, Ioannis S. Vizirianakis, Ioannis Pirmettis, Minas S. Papadopoulos, Dionysia Papagiannopoulou
Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent
Futao Liu, Seok Rye Choi, Zhihao Zha, Karl Ploessl, Lin Zhu, Hank F. Kung
Corrigendum to “131I-labeled chitosan hydrogels for radioembolization: a preclinical study in small animals” [Nucl Med Biol 52 (2017) 16–23]
Hyosook Hwang, Kwang Il Kim, JeongIl Kwon, Byoung Soo Kim, Hwan-Seok Jeong, Su Jin Jang, Phil-Sun Oh, Ho Sung Park, Seok Tae Lim, Myung-Hee Sohn, Hwan-Jeong Jeong
To gain complimentary access to the January 2018 issue, please select the image above.
To access the journal home page, click here.
To access instructions for authors and related content, click here.
If you are a member and experiencing difficulty accessing the journal online, please email Michael Bonds [M.Bonds(a)elsevier.com)]. Michael is our society liaison and typically responds in under 24 hours. You may also email our Executive Director, Charles Metzger [cmetzger(a)srsweb.org].